SNSE:SOPROCAL Statistics
Total Valuation
SNSE:SOPROCAL has a market cap or net worth of CLP 2.66 billion. The enterprise value is 2.64 billion.
| Market Cap | 2.66B |
| Enterprise Value | 2.64B |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE:SOPROCAL has 9.85 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 9.85M |
| Shares Outstanding | 9.85M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 10.06% |
| Owned by Institutions (%) | n/a |
| Float | 2.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 6.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of -12.08.
| EV / Earnings | -9.05 |
| EV / Sales | 0.20 |
| EV / EBITDA | 7.45 |
| EV / EBIT | n/a |
| EV / FCF | -12.08 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.58 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | -1.34 |
| Interest Coverage | -11.00 |
Financial Efficiency
Return on equity (ROE) is -5.01% and return on invested capital (ROIC) is -3.15%.
| Return on Equity (ROE) | -5.01% |
| Return on Assets (ROA) | -1.90% |
| Return on Invested Capital (ROIC) | -3.15% |
| Return on Capital Employed (ROCE) | -4.77% |
| Revenue Per Employee | 185.84M |
| Profits Per Employee | -4.11M |
| Employee Count | 71 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 3.17 |
Taxes
| Income Tax | -387.82M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 270.50 |
| 200-Day Moving Average | 270.50 |
| Relative Strength Index (RSI) | 75.99 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:SOPROCAL had revenue of CLP 13.19 billion and -291.71 million in losses. Loss per share was -29.63.
| Revenue | 13.19B |
| Gross Profit | 2.13B |
| Operating Income | -308.80M |
| Pretax Income | -679.72M |
| Net Income | -291.71M |
| EBITDA | 370.89M |
| EBIT | -308.80M |
| Loss Per Share | -29.63 |
Balance Sheet
The company has 300.43 million in cash and 293.97 million in debt, giving a net cash position of 6.46 million or 0.66 per share.
| Cash & Cash Equivalents | 300.43M |
| Total Debt | 293.97M |
| Net Cash | 6.46M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 5.68B |
| Book Value Per Share | 578.60 |
| Working Capital | 2.52B |
Cash Flow
In the last 12 months, operating cash flow was 408.21 million and capital expenditures -626.91 million, giving a free cash flow of -218.70 million.
| Operating Cash Flow | 408.21M |
| Capital Expenditures | -626.91M |
| Free Cash Flow | -218.70M |
| FCF Per Share | -22.20 |
Margins
Gross margin is 16.15%, with operating and profit margins of -2.34% and -2.21%.
| Gross Margin | 16.15% |
| Operating Margin | -2.34% |
| Pretax Margin | -5.15% |
| Profit Margin | -2.21% |
| EBITDA Margin | 2.81% |
| EBIT Margin | -2.34% |
| FCF Margin | n/a |
Dividends & Yields
SNSE:SOPROCAL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -10.95% |
| FCF Yield | -8.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:SOPROCAL has an Altman Z-Score of 2.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 4 |